» Articles » PMID: 38963354

Protamine and Heparin Interactions: A Narrative Review

Overview
Specialty Anesthesiology
Date 2024 Jul 4
PMID 38963354
Authors
Affiliations
Soon will be listed here.
Abstract

Protamine, first isolated from salmon fish sperm and now produced through recombinant biotechnology, is an antidote that neutralizes the anticoagulant properties of heparin. Protamine function is based on the capacity to dissociate the heparin-antithrombin III (AT III) complex (an important link that promotes blood fluidification by inhibiting coagulation), forming the inactive heparin-protamine complex. Protamine has itself dose-dependent anticoagulant properties: It interferes with coagulation factors and platelet function; it stimulates fibrinolysis; it can lead to thrombocytopenia and reduction in thrombin-related platelet aggregation; it decreases platelet response to thrombin receptor agonist in a dose-dependent manner. In this review, we will focus on protamine and its interaction with heparin. Notably, protamine is able to antagonize not only unfractionated heparin (UFH) but also low molecular weight heparins to various degrees. Protamine-allergic and anaphylactoid systemic reactions may affect up to 1 in 10 people and should be prevented and treated early.

Citing Articles

The Risk of Hemorrhage and Shunt Occlusion After Tonsillectomy in a Glenn Circulation Patient With Blalock-Taussig Shunt Dependence: A Case Report.

Hibino T, Okui Y, Toba Y Cureus. 2025; 17(2):e78682.

PMID: 40062094 PMC: 11890361. DOI: 10.7759/cureus.78682.


Serum Amyloid A Binding to Glycosaminoglycans is Synergistic with Amyloid Formation: Therapeutic Targeting in the Inflammation-linked Amyloidosis.

Jayaraman S, Urdaneta A, Fandrich M, Gursky O J Mol Biol. 2025; 437(8):169007.

PMID: 39954777 PMC: 11903164. DOI: 10.1016/j.jmb.2025.169007.

References
1.
JAQUES L . A study of the toxicity of the protamine, salmine. Br J Pharmacol Chemother. 1949; 4(2):135-44. PMC: 1509871. DOI: 10.1111/j.1476-5381.1949.tb00526.x. View

2.
Hsu K, Wang D, Shen C, Chiang C . Protamine-induced acute lung injury and the protective effect of agents that increase cAMP. Proc Natl Sci Counc Repub China B. 1993; 17(2):57-61. View

3.
Rath B, Bennett D . Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty. Br Heart J. 1990; 63(1):18-21. PMC: 1024308. DOI: 10.1136/hrt.63.1.18. View

4.
Tacquard C, Iba T, Levy J . Perioperative Anaphylaxis. Anesthesiology. 2022; 138(1):100-110. DOI: 10.1097/ALN.0000000000004419. View

5.
Shore-Lesserson L, Baker R, Ferraris V, Greilich P, Fitzgerald D, Roman P . The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass. Ann Thorac Surg. 2018; 105(2):650-662. DOI: 10.1016/j.athoracsur.2017.09.061. View